Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: A population-based case control study

BMC Women's Health

Volumn 11, Issue , 2011, Pages

  Bandera, Elisa V ^a,b   King, Melony ^b   Chandran, Urmila ^a,b   Paddock, Lisa E ^b,c   Rodriguez Rodriguez, Lorna ^a   Olson, Sara H ^d  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUMESTROL; DAIDZEIN; FORMONONETIN; GENISTEIN; GLYCITEIN; MATAIRESINOL; PHYTOESTROGEN; PINORESINOL; SECOISOLARICIRESINOL; ISOFLAVONE DERIVATIVE; LIGNAN;

ARTICLE; BODY MASS; CALORIC INTAKE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; EDUCATIONAL STATUS; FEMALE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; OVARY CANCER; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; RACE DIFFERENCE; SMOKING; SUPPLEMENTARY EYE FIELD; UNITED STATES; WOMEN'S HEALTH; ADULT; CASE CONTROL STUDY; CONFIDENCE INTERVAL; MIDDLE AGED; NEOPLASM; OVARIAN EPITHELIAL CANCER; OVARY TUMOR; REGRESSION ANALYSIS; RISK; SOYBEAN; STATISTICS;

ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; COUMESTROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; ISOFLAVONES; LIGNANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEW JERSEY; ODDS RATIO; OVARIAN NEOPLASMS; PHYTOESTROGENS; REGRESSION ANALYSIS; SOY FOODS; WOMEN'S HEALTH;

EID: 80053173084     PISSN: None     EISSN: 14726874     Source Type: Journal    
DOI: 10.1186/1472-6874-11-40     Document Type: Article

References (33)

1. Cancer Facts and Figures. American Cancer Society 2011,
2. Hankinson SE, Danforth KN. Ovarian Cancer. Cancer Epidemiology and Prevention 2006, 1013-1026. New York, NY: Oxford University Press, Schottenfeld D, Fraumeni JF, Jr, Third.
3. Fathalla MF. Incessant ovulation--a factor in ovarian neoplasia?. Lancet 1971, 2(7716):163.
4. Stadel BV. Letter: The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975, 123(7):772-774.
5. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998, 90(23):1774-1786. 10.1093/jnci/90.23.1774, 9839517.
6. Shan W, Liu J. Inflammation: a hidden path to breaking the spell of ovarian cancer. Cell Cycle 2009, 8(19):3107-3111. 10.4161/cc.8.19.9590, 19738436.
7. Bandera EV, Kushi LH. Phytoestrogens in the prevention and prognosis of female hormonal cancers. Annual Reviews in Food and Nutrition Toxicity 2004, 1:63-87.
8. Chen X, Anderson JJ. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr Cancer 2001, 41:(1-2):165-171.
9. Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998, 68(6 Suppl):1333S-1346S.
10. Karahalil B. Benefits and risks of phytoestrogens. Phytoestrogens in functional foods 2006, 203-239. Florida: CRC Press. Taylor and Francis Group, Yildiz F, edn.
11. Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada). Cancer Causes Control 2008, 19(3):259-272. 10.1007/s10552-007-9089-2, 17992574.
12. Saarinen NM, Warri A, Airio M, Smeds A, Makela S. Role of dietary lignans in the reduction of breast cancer risk. Mol Nutr Food Res 2007, 51(7):857-866. 10.1002/mnfr.200600240, 17576639.
13. Milder IE, Arts IC, van de Putte B, Venema DP, Hollman PC. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 2005, 93(3):393-402. 10.1079/BJN20051371, 15877880.
14. Zhang M, Yang ZY, Binns CW, Lee AH. Diet and ovarian cancer risk: a case-control study in China. Br J Cancer 2002, 86(5):712-717. 10.1038/sj.bjc.6600085, 2375319, 11875731.
15. Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer 2004, 49(2):125-130. 10.1207/s15327914nc4902_2, 15489204.
16. Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, et al. Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 2007, 165(7):802-813. 10.1093/aje/kwk065, 2093945, 17210953.
17. Sakauchi F, Khan MM, Mori M, Kubo T, Fujino Y, Suzuki S, Tokudome S, Tamakoshi A. Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer 2007, 57(2):138-145. 10.1080/01635580701274178, 17571946.
18. Rossi M, Negri E, Lagiou P, Talamini R, Dal Maso L, Montella M, Franceschi S, La Vecchia C. Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer 2008, 123(4):895-898. 10.1002/ijc.23549, 18491402.
19. Rossi M, Bosetti C, Negri E, Lagiou P, La Vecchia C. Flavonoids, proanthocyanidins, and cancer risk: a network of case-control studies from Italy. Nutr Cancer 2010, 62(7):871-877. 10.1080/01635581.2010.509534, 20924962.
20. McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003, 133(6):1937-1942.
21. Hedelin M, Lof M, Andersson TM, Adlercreutz H, Weiderpass E. Dietary Phytoestrogens and the Risk of Ovarian Cancer in the Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev 2011, 20(2):308-317. 10.1158/1055-9965.EPI-10-0752, 21098648.
22. Myung SK, Ju W, Choi HJ, Kim SC. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. BJOG 2009, 116(13):1697-1705. 10.1111/j.1471-0528.2009.02322.x, 19775307.
23. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutrition and cancer 2006, 54(2):184-201. 10.1207/s15327914nc5402_5, 16898863.
24. Chandran U, Bandera EV, Williams-King MG, Paddock LE, Rodriguez-Rodriguez L, Lu SE, Faulkner S, Pulick K, Olson SH. Healthy eating index and ovarian cancer risk. Cancer Causes Control 2011, 22(4):563-571. 10.1007/s10552-011-9728-5, 21286802.
25. Olson SH, Orlow I, Bayuga S, Sima C, Bandera EV, Pulick K, Faulkner S, Tommasi D, Egan D, Roy P, et al. Variants in hormone biosynthesis genes and risk of endometrial cancer. Cancer Causes Control 2008, 19(9):955-963. 2683972, 18437511.
26. Bandera EV, Williams MG, Sima C, Bayuga S, Pulick K, Wilcox H, Soslow R, Zauber AG, Olson SH. Phytoestrogen consumption and endometrial cancer risk: a population-based case-control study in New Jersey. Cancer Causes Control 2009, 20(7):1117-1127. 10.1007/s10552-009-9336-9, 2761755, 19353280.
27. Fortuny J, Sima C, Bayuga S, Wilcox H, Pulick K, Faulkner S, Zauber AG, Olson SH. Risk of endometrial cancer in relation to medical conditions and medication use. Cancer Epidemiol Biomarkers Prev 2009, 18(5):1448-1456. 10.1158/1055-9965.EPI-08-0936, 2763278, 19383893.
28. Caan B, Sternfeld B, Gunderson E, Coates A, Quesenberry C, Slattery ML. Life After Cancer Epidemiology (LACE) Study: a cohort of early stage breast cancer survivors (United States). Cancer Causes Control 2005, 16(5):545-556. 10.1007/s10552-004-8340-3, 15986109.
29. Horn-Ross PL, Barnes S, Lee M, Coward L, Mandel JE, Koo J, John EM, Smith M. Assessing phytoestrogen exposure in epidemiologic studies: development of a database (United States). Cancer Causes Control 2000, 11(4):289-298. 10.1023/A:1008995606699, 10843440.
30. Willett W, Stampfer M. Implications of total energy intake for epidemiologic analyses. Nutritional Epidemiology 1998, 273-301. New York: Oxford University Press, Willett W, Second.
31. Hartge P. Participation in population studies. Epidemiology 2006, 17(3):252-254. 10.1097/01.ede.0000209441.24307.92, 16617271.
32. New Jersey StateCancer Registry. Cancer Epidemiology Services. New Jersey Department of Health and Senior Services Primary Epithelial Ovarian Cancer in 6 NJ Counties, age-specific incidence rates by race and age, 2003-2006. November 2008 file, New Jersey StateCancer Registry. Cancer Epidemiology Services. New Jersey Department of Health and Senior Services.
33. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol 2007, 17(9):643-653. 10.1016/j.annepidem.2007.03.013, 17553702.